Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium fMRI in Bipolar Disorder
NCT00457054Phase 4Completed
- Sponsor
- Indiana University School of Medicine
- Start
- Jul 2003
- Primary completion
- Mar 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 4, open-label trial of lithium in bipolar disorder (BD) (2 arms), sponsored by Indiana University School of Medicine. Primary endpoints: Comparative activation of amygdala and cortico-amydalar connectivity at 8 weeks and Hamilton Depression Rating Scale at 8 weeks. Started Jul 2003; status: completed.
02
Drugs
lithium
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00457054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00457054.